These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35212066)

  • 1. A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Jiang YT; Chen KH; Liang ZG; Yang J; Wei SQ; Qu S; Li L; Zhu XD
    Head Neck; 2022 Jun; 44(6):1301-1312. PubMed ID: 35212066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics-based nomogram guides adaptive de-intensification in locoregionally advanced nasopharyngeal carcinoma following induction chemotherapy.
    Wang SX; Yang Y; Xie H; Yang X; Liu ZQ; Li HJ; Huang WJ; Luo WJ; Lei YM; Sun Y; Ma J; Chen YF; Liu LZ; Mao YP
    Eur Radiol; 2024 Oct; 34(10):6831-6842. PubMed ID: 38514481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dynamic nomogram combining tumor stage and magnetic resonance imaging features to predict the response to induction chemotherapy in locally advanced nasopharyngeal carcinoma.
    Jiang Y; Liang Z; Chen K; Li Y; Yang J; Qu S; Li L; Zhu X
    Eur Radiol; 2023 Mar; 33(3):2171-2184. PubMed ID: 36355201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining tumor response and personalized risk assessment: Potential for adaptation of concurrent chemotherapy in locoregionally advanced nasopharyngeal carcinoma in the intensity-modulated radiotherapy era.
    Luo WJ; Zou WQ; Liang SB; Chen L; Zhou GQ; Peng H; Li WF; Liu X; Sun Y; Lin AH; Ma J; Mao YP
    Radiother Oncol; 2021 Feb; 155():56-64. PubMed ID: 33039423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishing and applying nomograms based on the 8th edition of the UICC/AJCC staging system to select patients with nasopharyngeal carcinoma who benefit from induction chemotherapy plus concurrent chemoradiotherapy.
    Xu C; Chen YP; Liu X; Li WF; Chen L; Mao YP; Zhang Y; Guo R; Zhou GQ; Tang LL; Lin AH; Sun Y; Ma J
    Oral Oncol; 2017 Jun; 69():99-107. PubMed ID: 28559028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multidimensional nomogram combining overall stage, dose volume histogram parameters and radiomics to predict progression-free survival in patients with locoregionally advanced nasopharyngeal carcinoma.
    Yang K; Tian J; Zhang B; Li M; Xie W; Zou Y; Tan Q; Liu L; Zhu J; Shou A; Li G
    Oral Oncol; 2019 Nov; 98():85-91. PubMed ID: 31569054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Nomogram For Locoregionally Advanced Nasopharyngeal Carcinoma.
    Jiang Y; Qu S; Pan X; Huang S; Zhu X
    Sci Rep; 2020 Jan; 10(1):861. PubMed ID: 31965045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Yang K; Li M; Zhu J; Zeng L; Tian J; Xie W; Shou A; Li Y; Li G
    Head Neck; 2021 Jun; 43(6):1838-1847. PubMed ID: 33605501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
    Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X
    BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Epstein-Barr virus DNA level post induction chemotherapy contributes to prognostication in advanced-stage nasopharyngeal carcinoma.
    Chen FP; Luo YS; Chen K; Li JY; Huo LQ; Shi L; Ou-Yang Y; Cao XP
    Eur J Cancer; 2021 Jul; 151():63-71. PubMed ID: 33964573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of a Prognostic Nomogram for Patients With Locoregionally Advanced Nasopharyngeal Carcinoma Incorporating TNM Stage, Post-Induction Chemotherapy Tumor Volume and Epstein-Barr Virus DNA Load.
    Jiang YT; Chen KH; Yang J; Liang ZG; Qu S; Li L; Zhu XD
    Front Oncol; 2021; 11():683475. PubMed ID: 34222003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based radiomics nomogram may predict the response to induction chemotherapy and survival in locally advanced nasopharyngeal carcinoma.
    Zhao L; Gong J; Xi Y; Xu M; Li C; Kang X; Yin Y; Qin W; Yin H; Shi M
    Eur Radiol; 2020 Jan; 30(1):537-546. PubMed ID: 31372781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.
    Sun XS; Xiao ZW; Liu SL; Sun R; Luo DH; Chen QY; Mai HQ
    Eur Radiol; 2023 May; 33(5):3682-3692. PubMed ID: 36735041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI-Based Back Propagation Neural Network Model as a Powerful Tool for Predicting the Response to Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma.
    Liao H; Chen X; Lu S; Jin G; Pei W; Li Y; Wei Y; Huang X; Wang C; Liang X; Bao H; Liu L; Su D
    J Magn Reson Imaging; 2022 Aug; 56(2):547-559. PubMed ID: 34970824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
    Liu SL; Sun XS; Xie HJ; Chen QY; Lin HX; Liang H; Liang YJ; Li XY; Yan JJ; Lin C; Yang ZC; Guo SS; Liu LT; Tang QN; Du YY; Tang LQ; Guo L; Mai HQ
    BMC Cancer; 2020 Feb; 20(1):89. PubMed ID: 32013967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta magnetic resonance imaging radiomics features‑based nomogram predicts long‑term efficacy after induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Pan GS; Sun XM; Kong FF; Wang JZ; He XY; Lu XG; Hu CS; Dong SX; Ying HM
    Oral Oncol; 2024 Oct; 157():106987. PubMed ID: 39133972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying optimal candidates for induction chemotherapy among stage II-IVa nasopharyngeal carcinoma based on pretreatment Epstein-Barr virus DNA and nodal maximal standard uptake values of [
    Xie HJ; Yu YF; Sun XS; Jia GD; Luo DH; Sun R; Liu LT; Guo SS; Liu SL; Chen QY; Tang LQ; Mai HQ
    Cancer Med; 2020 Dec; 9(23):8852-8863. PubMed ID: 33034945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. External validity of a prognostic nomogram for locoregionally advanced nasopharyngeal carcinoma based on the 8th edition of the AJCC/UICC staging system: a retrospective cohort study.
    OuYang PY; You KY; Zhang LN; Xiao Y; Zhang XM; Xie FY
    Cancer Commun (Lond); 2018 Sep; 38(1):55. PubMed ID: 30176932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of magnetic resonance imaging-derived skeletal muscle index in locoregionally advanced nasopharyngeal carcinoma.
    Jiang J; Cai Z; Zheng R; Yuan Y; Lv X; Qiu W
    Eur Arch Otorhinolaryngol; 2024 Jul; 281(7):3707-3715. PubMed ID: 38671169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Nomogram Model for Treatment of Nonmetastatic Nasopharyngeal Carcinoma.
    Zhang LL; Xu F; Song D; Huang MY; Huang YS; Deng QL; Li YY; Shao JY
    JAMA Netw Open; 2020 Dec; 3(12):e2029882. PubMed ID: 33306119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.